Dipna Pharmachem Limited (BOM:543594)
India · Delayed Price · Currency is INR 5.44
-0.15 (-2.68%)
At close: Jul 15, 2026
Dipna Pharmachem Market Cap
Dipna Pharmachem has a market cap or net worth of 146.96 million as of July 15, 2026. Its market cap has decreased by -76.30% in one year.
Market Cap
146.96M
Enterprise Value
267.15M
Revenue
1.29B
Ranking
n/a
PE Ratio
5.59
Stock Price
5.44
Market Cap Chart
Since September 8, 2022, Dipna Pharmachem's market cap has decreased from 399.80M to 146.96M, a decrease of -63.24%. That is a compound annual growth rate of -22.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 146.96M | -66.92% |
| Dec 30, 2025 | 444.29M | 28.22% |
| Dec 31, 2024 | 346.49M | 171.80% |
| Dec 29, 2023 | 127.48M | -47.79% |
| Dec 30, 2022 | 244.19M | -38.92% |
| Sep 8, 2022 | 399.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Goldline Pharmaceutical | 387.74M |
| Chandra Bhagat Pharma | 290.86M |
| Medico Intercontinental | 275.30M |
| Medistep Healthcare | 262.88M |
| Pentokey Organy (India) | 228.26M |
| Zenlabs Ethica | 226.55M |
| Centuple Global | 216.33M |
| Muller & Phipps (India) | 138.13M |